Diseases, Conditions, Syndromes

Meta-analysis compares tx for inducing remission in Crohn's

(HealthDay)—For adult patients with Crohn's disease, adalimumab and infliximab + azathioprine are most effective for induction and maintenance of remission, according to a meta-analysis published in the February issue of ...

Diseases, Conditions, Syndromes

Impaired sleep ups risk of relapse in Crohn's disease

(HealthDay)—For patients with Crohn's disease (CD), but not ulcerative colitis, sleep impairment is associated with increased risk of relapse, according to a study published in the August issue Clinical Gastroenterology ...

Inflammatory disorders

Therapy for severe vasculitis shows long-term effectiveness

Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study ...

Inflammatory disorders

One in five kids may 'outgrow' asthma

(HealthDay)— As many as one in five youngsters with asthma may grow out of the respiratory condition as they age, new research indicates.

page 3 from 4